Showing results (71-80 of 254) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|June 29, 2005
Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disordersSimon D J Gibbs, David A Westerman, Christopher McCormack, et al.
Haematologica|January 26, 2006
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five casesAshley P Ng, Stephen Lade, Timothy Rutherford, et al.
Cancer Medicine|December 17, 2016
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphomaFrancine Foss, Barbara Pro, H Miles Prince, et al.
Thrombosis Research|May 7, 2013
Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptideMark J Bishton, Elizabeth E Gardiner, Simon J Harrison, et al.
Pathology|March 21, 2002
Cutaneous lymphomas: which pathological classification?H Miles Prince, Rod O'Keefe, Christopher McCormack, et al.
The Australasian Journal of Dermatology|April 29, 2009
Successful treatment of lymphomatoid papulosis with photodynamic therapyMichelle Rodrigues, Christopher McCormack, Lee-Mei Yap, et al.
Plastic and Reconstructive Surgery|February 22, 2019
The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast ImplantsMark Magnusson, Kenneth Beath, Rodney Cooter, et al.
Leukemia & Lymphoma|December 25, 2025
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic optionsFriyana Bhabha, H Miles Prince, Belinda Campbell, et al.
Cancer|May 13, 2004
Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignanciesConstantine S Tam, Max M Wolf, E Henry Januszewicz, et al.
Haematologica|December 7, 2005
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantationAshley P Ng, Leon Worth, Luke Chen, et al.
Pageof 26